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Departments of 1Vascular Surgery, and 2Anesthesiology, Erasmus MC Rotterdam, The NetherlandsAs confirmed in the study of Ali et al. patients undergo-
ing open abdominal aortic aneurysm repair are at high
perioperative and long-term cardiac risk. Therefore,
these patients should ideally be identified at the preop-
erative screening visit. This offers a golden opportunity
for clinicians to address both unfavourable lifestyle
habits aswell as instituting aggressivemedical risk fac-
tor management. Several risk factors that predict ad-
verse perioperative as well as adverse long-term
outcome can be identified and treated at this stage.
According to the Customized Probability Index by
Kertai et al. the type of surgery is a strong risk factor;
patients with a ruptured abdominal aortic aneurysm
have the worst outcome, followed by elective thora-
coabdominal and abdominal aortic surgery.1 Risk fac-
tors based on medical history, ordered in descending
risk, were: renal dysfunction, congestive heart failure,
ischemic heart disease, cerebrovascular event, hyper-
tension, and pulmonary disease. Interestingly, these
factors also predict long term outcome in vascular
surgery patients.
In addition to clinical risk factors biomarkers such
as hsCRP have emerged as potential predictors of ad-
verse cardiovascular events after vascular surgery. As
shown by Owens et al. in a group of 91 vascular sur-
gery patients, a preoperative hsCRP level >5 mg/l
was associated with a 2.3-fold increased risk for ad-
verse cardiovascular events during a mean follow-
up of 12 months.2
Another well known biomarker, in the current study
assessedafter the stress of surgery, is troponin release. ItDOI of original article: 10.1016/j.ejvs.2007.10.007.
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ative troponinTrelease>0.03 ng/ml and/or a troponin
I release >0.6 ng/ml had a significant independent
2-fold increased risk for long-term mortality during
a mean follow-up of 32 months.3 This was confirmed
in a study of 393 vascular surgery patients by Kertai
et al.: an increase in troponin T level >0.1 ng/ml was
associated with a 1.9-fold increased risk for all-cause
mortality during a median follow-up of 4 years.4
Although the combination of clinical cardiac risk fac-
tors andbiomarkers offers auniqueopportunity to strat-
ify patients according to the long-term risk, outcome in
patients with peripheral arterial disease remains poor.
The 5-year event rate of cerebrocardiovascular events
is approximately 20% with mortality rates of up to
30%. TheReduction ofAtherothrombosis for Continued
Health (REACH) Registry, including 55 814 patients
with known atherosclerotic disease showed that pa-
tients with PAD or a combination of PAD and CAD
have a significant worse outcome compared to patients
with CAD only.5 An explanation for the high event rate
is the medical undertreatment of patients with PAD.
This was also recently confirmed in a report from
Denmark. There is substantial evidence that medical
risk factor management is associated with an improved
event-free survival. In fact, current guidelines recom-
mend the aggressive use of statins, antiplatelet therapy,
and blood pressure lowering agents in these patients.6
Yet implication of these guidelines into clinical practice
is time-consuming.
For the improvement of long-term prognosis of pa-
tients with AAA it is advisable that current guidelines
on lifestyle changes and treatment targets of cardiac
risk factors are fully disseminated among physicians
involved in care of these patients. The routine peri-
operative measurement of troponins might furtherr Surgery. Published by Elsevier Ltd. All rights reserved.
421Risk Prediction in Patients Undergoing AAA Repairguide clinicians in selecting patients that require more
aggressive medical treatment.References
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